Rhythm Biosciences (FRA:0RY) COGS-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Rhythm Biosciences COGS-to-Revenue?

Rhythm Biosciences's Cost of Goods Sold for the six months ended in Dec. 2023 was €0.00 Mil. Its Revenue for the six months ended in Dec. 2023 was €0.00 Mil.

Rhythm Biosciences's COGS to Revenue for the six months ended in Dec. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Rhythm Biosciences's Gross Margin % for the six months ended in Dec. 2023 was N/A%.

Rhythm Biosciences COGS-to-Revenue Historical Data

The historical data trend for Rhythm Biosciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences COGS-to-Revenue Chart

Rhythm Biosciences Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

COGS-to-Revenue

Get a 7-Day Free Trial

Rhythm Biosciences Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial								-	-	-	-	-

Rhythm Biosciences COGS-to-Revenue Calculation

Rhythm Biosciences's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Rhythm Biosciences's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Rhythm Biosciences (FRA:0RY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Rhythm Biosciences's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Rhythm Biosciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences (FRA:0RY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (FRA:0RY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

RHY:Australia

Address

30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010

Website

https://www.rhythmbio.com

Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (FRA:0RY) Headlines

No Headlines